000 | 01530 a2200409 4500 | ||
---|---|---|---|
005 | 20250516182155.0 | ||
264 | 0 | _c20140805 | |
008 | 201408s 0 0 eng d | ||
022 | _a1873-264X | ||
024 | 7 |
_a10.1016/j.jpba.2013.10.021 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLiu, Mingtao | |
245 | 0 | 0 |
_aHPLC method development, validation and impurity characterization for an antitumor Hsp90 inhibitor-PU-H71 (NSC 750424). _h[electronic resource] |
260 |
_bJournal of pharmaceutical and biomedical analysis _cFeb 2014 |
||
300 |
_a34-41 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
650 | 0 | 4 |
_aBenzodioxoles _xchemistry |
650 | 0 | 4 |
_aChromatography, High Pressure Liquid _xmethods |
650 | 0 | 4 | _aDrug Contamination |
650 | 0 | 4 | _aDrug Stability |
650 | 0 | 4 |
_aHSP90 Heat-Shock Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aHydrogen-Ion Concentration |
650 | 0 | 4 |
_aMass Spectrometry _xmethods |
650 | 0 | 4 | _aOxidation-Reduction |
650 | 0 | 4 | _aPhotolysis |
650 | 0 | 4 |
_aPurines _xchemistry |
650 | 0 | 4 | _aSensitivity and Specificity |
700 | 1 | _aWang, Jennie | |
700 | 1 | _aWu, Xiaogang | |
700 | 1 | _aWang, Euphemia | |
700 | 1 | _aBaptista, Diego | |
700 | 1 | _aScott, Brendan | |
700 | 1 | _aLiu, Paul | |
773 | 0 |
_tJournal of pharmaceutical and biomedical analysis _gvol. 89 _gp. 34-41 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpba.2013.10.021 _zAvailable from publisher's website |
999 |
_c23285677 _d23285677 |